Related references
Note: Only part of the references are listed.Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells
Amy M. Cook et al.
BLOOD (2014)
Enhanced Arginine Methylation of Programmed Cell Death 4 Protein during Nutrient Deprivation Promotes Tumor Cell Viability
Marta M. Fay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Drug Design Targeting Protein-Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface
Huameng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing
Jihyun Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Overexpression of PRMT5 Promotes Tumor Cell Growth and Is Associated with Poor Disease Prognosis in Epithelial Ovarian Cancer
Xiangxiang Bao et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia
A. Mims et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27Kip1
Courtney Nicholas et al.
PLOS ONE (2013)
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB
Han Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Protein arginine methyltransferases and cancer
Yanzhong Yang et al.
NATURE REVIEWS CANCER (2013)
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
Zhongping Gu et al.
BIOCHEMICAL JOURNAL (2012)
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
William Blum et al.
BLOOD (2012)
HOXA9 Methylation by PRMT5 Is Essential for Endothelial Cell Expression of Leukocyte Adhesion Molecules
Smarajit Bandyopadhyay et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1
Yi-Kun Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
Fan Liu et al.
CANCER CELL (2011)
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)
Huameng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression
Gerhard Rank et al.
BLOOD (2010)
Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
Shujun Liu et al.
CANCER CELL (2010)
Evaluation of the Performance of Four Molecular Docking Programs on a Diverse Set of Protein-Ligand Complexes
Xun Li et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
William Blum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA 29b functions in acute myeloid leukemia
Ramiro Garzon et al.
BLOOD (2009)
FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML
Ellen Weisberg et al.
DRUG RESISTANCE UPDATES (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
PRMT5 is required for cell-cycle progression and p53 tumor suppressor function
A. Scoumanne et al.
NUCLEIC ACIDS RESEARCH (2009)
Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors
Dawid Eckert et al.
BMC DEVELOPMENTAL BIOLOGY (2008)
Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells
Li Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Arginine methylation regulates the p53 response
Martin Jansson et al.
NATURE CELL BIOLOGY (2008)
Arginine methylation at a glance
Mark T. Bedford
JOURNAL OF CELL SCIENCE (2007)
Interplay between chromatin remodelers and protein arginine methyltransferases
Sharmistha Pal et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Sharmistha Pal et al.
EMBO JOURNAL (2007)
MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties
X Le Guezennec et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Arginine methylation regulates IL-2 gene expression:: a role for protein arginine methyltransferase 5 (PRMT5)
S Richard et al.
BIOCHEMICAL JOURNAL (2005)
Arginine methylation: An emerging regulator of protein function
MT Bedford et al.
MOLECULAR CELL (2005)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad
S Pal et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Negative regulation of transcription by the type II arginine methyltransferase PRMT5
E Fabbrizio et al.
EMBO REPORTS (2002)